Influence of Sex in the Development of Liver Diseases
Seminars in Liver Disease · 01.03.2025 · 45 (01) · 015-032
DOI: 10.1055/a-2516-0261 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.03.2025. Verfasst von Jie-Wen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China. Hauptthemen laut MEDLINE: Liver Diseases, Gonadal Steroid Hormones, Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 224 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The liver is a sexually dimorphic organ. Sex differences in prevalence, progression, prognosis, and treatment prevail in most liver diseases, and the mechanism of how liver diseases act differently among male versus female patients has not been fully elucidated. Biological sex differences in normal physiology and disease arise principally from sex hormones and/or sex chromosomes. Sex hormones contribute to the development and progression of most liver diseases, with estrogen- and androgen-mediated signaling pathways mechanistically involved. In addition, genetic factors in sex chromosomes have recently been found to contribute to the sex disparity of many liver diseases, which might explain, to some extent, the difference in gene expression pattern, immune response, and xenobiotic metabolism between men and women. Although increasing evidence suggests that sex is one of the most important modulators of disease prevalence and outcomes, at present, basic and clinical studies have long been sex unbalanced, with female subjects underestimated. As such, this review focuses on sex disparities of liver diseases and summarizes the current understanding of sex-specific mechanisms, including sex hormones, sex chromosomes, etc. We anticipate that understanding sex-specific pathogenesis will aid in promoting personalized therapies for liver disease among male versus female patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.
- Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.
- National-Local Joint Engineering Research Center for Precision Surgery and Regenerative Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J. W., Zhang, N., Lyu, Y., & Zhang, X. F. (2025). Influence of Sex in the Development of Liver Diseases. Seminars in Liver Disease, 45(01), 015-032. https://doi.org/10.1055/a-2516-0261
Vancouver
Zhang JW, Zhang N, Lyu Y, Zhang XF. Influence of Sex in the Development of Liver Diseases. Seminars in Liver Disease. 2025;45(01):015-032. doi:10.1055/a-2516-0261
BibTeX
@article{Zhang2025,
author = {Zhang, Jie-Wen and Zhang, Nan and Lyu, Yi and Zhang, Xu-Feng},
title = {Influence of Sex in the Development of Liver Diseases},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {01},
pages = {015--032},
doi = {10.1055/a-2516-0261}
}
EUVIMED